PRIK AZI BOLESNIK A
ѿЬѸѬѯѸЧќялѭѳЦѯЭдяЦѯєѿЬѸѬѯЬЭЦѯєлќЬїѳ
дяѳялѳїдяѿдьЦЬйѳдядьЦѯфбѿЧьЭЬ
ŶÁ¨®Ñ¯½Æº¬È¢©Í¨¹ÑÒÑËÂȯº©Ë¨¸ÒÑÍȽÅȢ˨¸ÑÒǦÅƺ© ÒÀʨʶÊÓѪ§ÑÊθ⨵¶½¸¨Ò¨´»¨®ÒÊÑ¿³¿¾¨µÍβ¿ÑÃ
ƭƳƢƵƢƭƴƢƧƳƩƢNJ
ƮǚǞǦǠǞǗǜǣǤǢǑǟǠǖǥǣǟǠǔǝǚǞǦǠǚǖǟǠǔǤǜǚǓǑǥǣǑǣǤǑǓǥǣǝǥǙǟǚǨǑ mucosa-associated lymphoid tissue=MALTǹǗǥǘǚǘǚǚǟǤǗ
ǢǗǣǠǓǑǻǑǥǡǠǣǝǗǖǻǚǧǖǓǑǖǗǣǗǤǑǜǔǠǖǚǟǑǙǒǠǔǣǓǠǹǚǧǡǑǤǠǝǠǪǜǚǧǚǜǝǚǟǚǩǜǚǧǠǣǠǒǗǟǠǣǤǚƶǡǚǤǑǻǥǹǗBǼǗǝǚǹǣǜǑǟǗǠǡǝǑ ǙǞǑǜǠǹǑǹǗǟǑǣǤǑǝǑǗǜǣǤǢǑǟǠǖǥǣǟǠǜǠǹǑǠǣǤǑǹǗǝǠǜǑǝǚǙǠǓǑǟǑǖǥǔǠǓǢǗǞǗǟǑǥǜǑǙǥǹǥǼǚǟǑǚǟǖǠǝǗǟǤǟǚǞǑǝǚǔǟǚǤǗǤƴǞǑǤǢǑǣǗ ǖǑǹǗǠǓǑǓǢǣǤǑǝǚǞǦǠǡǢǠǝǚǦǗǢǑǨǚǠǟǗǟǗǠǡǝǑǙǞǗǡǠǜǢǗǟǥǤǑǧǢǠǟǚǩǟǠǞǑǟǤǚǔǗǟǠǞǣǤǚǞǥǝǑǨǚǹǠǞƵǠǞǗǥǡǢǚǝǠǔǔǠǓǠǢǚǚ ǩǚǻǗǟǚǨǑǖǑǣǗǠǓǑǓǢǣǤǑǓǑǟǘǝǗǙǖǑǟǠǔǝǚǞǦǠǞǑǩǗǣǤǠǟǑǝǑǙǚǟǑǞǗǣǤǚǞǑǜǠǹǚǣǥǙǑǧǓǑǼǗǟǚǧǢǠǟǚǩǟǚǞǙǑǡǑǺǗǻǗǞǜǑǠ ǪǤǠǣǥǣǝǥǙǟǚǨǗǘǗǝǥǨǑǢǗǣǡǚǢǑǨǚǠǟǠǔǤǢǑǜǤǑǡǺǥǓǑǩǟǚǧǘǝǗǙǖǑǚǪǤǚǤǑǣǤǗǘǝǗǙǖǗƱǓǠǠǒǠǺǗǻǗǢǗǤǜǠǟǑǣǤǑǹǗǥǖǠǹǨǚ ǹǗǤǢǚǒǥǒǢǗǔǥǚǘǥǩǟǠǹǜǗǣǚƲǢǚǞǑǢǟǚǝǚǞǦǠǞǚǠǢǒǚǤǗǩǚǟǗǣǓǚǧǗǜǣǤǢǑǟǠǖǥǣǟǚǧǝǚǞǦǠǞǑǑǟǑǹǩǗǪǼǗǙǑǧǓǑǼǗǟǗ ǤǜǚǓǟǗǣǤǢǥǜǤǥǢǗǣǥǜǠǟǹǥǟǜǤǚǓǑǠǩǟǚǜǑǡǑǜǚǢǗǤǢǠǒǥǝǒǥǣǟǠǤǜǚǓǠƣǠǝǗǣǤǣǗǥǣǥǙǟǠǹǘǝǗǙǖǚǓǗǠǞǑǢǗǤǜǠǹǑǓǺǑǤǑǜǠǖǑǣǥ ǡǠǖǑǨǚǥǝǚǤǗǢǑǤǥǢǚǠǞǑǟǚǦǗǣǤǑǨǚǹǑǞǑǟǑǩǚǟǚǞǑǝǗǩǗǻǑǚǡǢǗǡǠǢǥǜǑǞǑǙǑǟǑǖǙǠǢMALTǝǚǞǦǠǞǑǣǥǙǟǗǘǝǗǙǖǗǠǣǜǥǖǟǚ ƲǢǚǜǑǙǑǝǚǣǞǠǒǠǝǗǣǟǚǜǑǣǡǢǚǞǑǢǟǠǞǝǠǜǑǝǚǙǑǨǚǹǠǞMALTǝǚǞǦǠǞǑǥǣǥǙǟǠǹǘǝǗǙǖǚǜǠǹǚǹǗǥǣǡǗǪǟǠǝǗǩǗǟǡǢǚǞǗǟǠǞǧǚ
ǢǥǢǪǜǚǧǞǗǤǠǖǑǚǙǢǑǩǟǗǤǗǢǑǡǚǹǗ TDGy
ƭǺǥǩǟǗǢǗǩǚMALTǝǚǞǦǠǞǣǥǙǟǑǘǝǗǙǖǑǢǑǖǚǠǤǗǢǑǡǚǹǑ
UVOD
Ç¿¨§Ñ¿Ò¨ ¸¨§ÖΧ¨ ο¾¨Ê Òѵ´¼¤ ÓѪÔÑÊѵ¶ δҨ»ÑÉÑ»À¶ÓÒ¶Á¸Óö»ÎÒµ¶Ò»Ê¨Ô¶¨¿Ê¿Î¾¶¸ ¾¶ÀÒÎÊ»¨ÔÎ#%ѵ´¼¤À¶¶É¨ÊÑ ¶¸¨§ÖΧ¨»À Ê¿ÑÒÎöÀÒβ¸¨§ÖÒβʻ¨ÔѶÀÑÀÊÑÔ¶À¸¶ÓÒ¨®Ñ mu-cosa-associated lymphoid tissue5MALTÀ¨ÒÃθÒÊ
Ò¨§ÊλΧ½ÑÎÓÑÀ¾ÑÒÒʨÊʧ±¶ÒªÎ´»¨ÒÀ»¨§
limfomima,MALTlimfom je precizno definisan
É¿ÔÎ É¿§Ñ É¿ÎÉÎÓ¨®¨µÑ§Ñ ÅԨè¿ÑÒ Ô¿ÎÉÀ»Î
ѧ¿¨´»»¸ÑÀ¨Ö¨»Ñ®¨µ¸¨§Ö뤄 REAL#%Ñ»Ñ
ÀÒ¨µ¨É¿§Ñ»¸ÑÀ¨Ö¨»Ñ®¨µ¨¸¨§ÖΨÃÒ¨ªÒÎÉ¸Ñ Ó§¨³ÔÊÀ»ÓÿÑÔÀÊÔÒο²ÑÒ¨ÓÑ®¨µ#%Ш§ÖΧ ¸¨§ÖΨÃÒβ Ê»¨ÔÑ Óÿ¶ÁÒβ À §¶»ÎÓΧ É¿ÃÀÊÑ Ô¹ÑÒÎɸÑÓ§¶§Ñ¸¨ª¸¨§Öή¨ÊÑÉο»¸Î§¨Ó§Ñ¿
ginalne zone limfnih folikula, a tumorsku masu
´¨Ò§Ñ¸¨¸¨§Öή¨Ê¨É¿Î§Ò¹¨Ô¤¸¨µÀ»Ñʨɨ
je pomešani sa monocitoidnimB¤¸¨µÑ§ÑËⶤ
µ¶Î´¨Ê¨¨É¸Ñӧή¨ÊΨÃÒ¤¸¨µÀ»Î¾¸¨»¦¨É¨´
ÒѧοÖθμ»ÑÎÀξ¨ÒѸ¨§ÖΧÑMALTµ¸¨§ÖÎ
ɨʸÒѸӨµÑ»ÎµÑÉ¿ÃÀÊÑԹѨÒÔÑÓ¨µ¶§¶»ÎÓʶ §Î¿À»¨§¤¸¨µÑ§Ñ¶Ô¨Ã¶»¸ÑÀÊ¿Ñ
³§ÑÊ¿ÑÀÃѵÎÔÑÔ¿ÀÊѸ¨§ÖÎɿθ¨Ö¿Ñ®¨Î ÒÒÎɸÑÓ§Éλ¿Ò¶ÊѪ¿ÎÒ¨´ÒΧÑÒʨ²ÒΧÀʨ §¶¸Ñ®¨µÎ§¦Î§¶É¿¨¸Î²²ÎÔ﨨´¨ Ò¨®ÑÃÑÀ ÎÔÑÔ¿ÀÊÑÔÑÒÁ¸ÓÃÑÒβ¸¨§ÖΧѴÀÊÎÒѸÑÓ¨ÒÑ §Àʨ§Ñ»ÎµÑÀ¶ÓѪÔѤÒѪ¿ÎÒ¨´Ò¨§ÓÑÉѹ § »ÑμÊÎÀ¶À¸¶ÓÒ¨®Á¸¶®Ñ¿Àɨ¿Ñ®¨ÎÒβʿѻ ÊÑɹ¶ÔÑ´Ò¨ª¨À¶ÓÒ¨ªÁ¸ÓÃѨ¼Ê¨ÊÑÀÊÁ¸Óà #%ÆÔÎξι ¿Ê»ÎÒÑÀÊѵ¶Ã宨µÊ¿¨¾¶ ¾¿²¶Á¶´Òε»À¨¨»ÎÒµ¶Ò»Ê¨ÔѧÑÆÃÀÔ¨ª¸¨§ÖÎ
§Ñο¾¨Ê´¨Ò¸¨§ÖΧ¨MALT£Éο± ¶ÀÑ
nodusnimB¸¨§ÖΧ¨§ÑÀ§Ñ¸¨§¿¨Ó¨»Î§ÓÑÒÑÀÊÑ
Òѻξι ѻε¨Éοø¨§ÖÒ¨ªÁ¸ÓÃѧβ¶ÃÑÓÑ
ªÔÑʨ»ÎÀÊÒ¶À¿ÁMALTlimfomi malog stepena
§Ñ¸¨²ÒÎÀʨÀ¶Î¾¨´ÒÎβ¿ÑÒ¨´Ò¨ÒѧÀÊΨÀªÎè
¼ÊÑ ÀÊÑ赶§IEiIIEÀµÑԹѻÎþθÀÒ¨»Ñ
ÆÔÑ»Îβ¿ÑÒ¨´Ò¨Î¾¸¨®¨¾Î¸ÀʨÒѵ´¼¤¨§Ñµ¶ ¨ÒÃθÒÊÑÒ»¶¿ÀÑÉÊβÎè¼ É¿Á¨Ô¹ÑÔÑ ¾Î
¸ÀÒ¨»ÑµÆɨÀÑÒ¨À¶¨¾Î¸ÀÒ¨®¨À¶Ãѹ Ò¨§É¿¨§Ñ¿Ò¨§ÁÑ¿¨¼Ê¨§Ñ»Îµ¨À¶Ô¿¸Î¿Ê»¨#% ÍθÀÊÀµÑԹѻÎÃÎÀξÑÀÊÑ¿¨µ²Á¨ÔÎÊÒβÃξÑÑ
É¿¨ÉÎÀÊÑÔ¹Ñ ¶Ã¨µÑ²ÒÎÓBÀ¨§ÉÊΧ¨À¶Î´ÑÔѵ¶
»ÎÃÀѧξθÀÒ¨»Ñ#%Ç¿¨»ÑÓ¶µ§Î¾Î¸ÀÒ¨»Ñ
s primarnimMALT¸¨§ÖΧΧÃÀÒÀ¶ÓÒÁ¸ÓÃ
»Îµ¨µ¶ÀɼÒθ´ÒÉ¿¨§ÒΧª¨¿¶¿¼»¨ª§ÊÎÃÑ ¨¸Î»Ñ¸ÒÓ¿Ñ´ÒÊ¿Ñɨµ
ѱѭЬќѳьѻѯѿЧяЦЬќѳ
ÍθÀÒ¨»ÀÊÑ¿²ÎèҵÑÔ¨ÎÀ¸»Ñ¿¶Ó¾Î²ÎÊÎ
ka lateralnog dela gorweg desnog kapka i pritiska
ÒÑÃÀÒÎλÎÆÔʲξÀ¶Ê¿ÑµÑ¸ÉÎÀ¸Ã ÃÔ²Î Ã¨Ò Ñ À¨ÀʧÀ» ʲξ Ò¨µ ÓÑÉÑӨΠĨӨ´»¨§ É¿²¸ÃΧ¶Î´Ò¨À¶ÓÒѴѵÑÒÎÊλ¨Ê¶§Î¿¸ÑʿѸ ÒβøÑÃÀÒο¾¨ÊÀ¶ÁÒδҨɿοӨÉÎʨÀÒ¶ ÊÑÃÀÒÑξ¿ÔÑÒѲο ³¸¨»Ñº¨Ã¨§Îʨ¸¨ÊÊà ÀÒβλÑÀ¶¾¨¸¨Î´¶ÔÑҨǿ¨Ö¿Ò¸¨§ÖÑÃÒÎÉÑ Ê¨µ¨ÀɸÒΪÉÑÊΧ²Ñ¸¨µÒ¨µ¾¨¸Î£¿Ñ±ÒÑÀ¶ ÉÎÊɶÒѸѾοÑÊ卑À»Ñ¨¿Ñèβ¿ÑÖÀ»Ñ¨ÀɨʨÔÑ Ñ»ÑΨ¾¨ÎÉÀ¨µÑ»ÎÀÊÒÀ¿Á¨ÑÒѸÑÓ¶»Î§Éµ¶
BIBLID: 0370-8179, 133(2005) 5-6 p. 272-275 UDC: 617.764.1-006-08:615.849
SLIKA 1.ƷǚǙǚǩǜǚǞǡǢǗǔǝǗǖǠǞǥǠǩǗǟǚǣǥǙǟǑǩǑǹǑǟǠǤǠǜǚǤǥǞǠǢ ǝǑǤǗǢǑǝǟǠǔǖǗǝǑǖǗǣǟǗǠǢǒǚǤǗǣǥǘǗǟǠǩǟǚǡǢǠǢǗǙǚǡǠǤǚǣǟǥǤǑǖǗ ǣǟǑǠǒǢǓǑǟǑǔǠǢǗ
ƴƳƲƴƭƫƢƳƸƫƤƪƢƹƨƮƱƭƶƲưƱƮƨƭƢƳƴƵƤƱ
SLIKA 2.ƭǠǞǡǹǥǤǗǢǚǙǠǓǑǟǠǞǤǠǞǠǔǢǑǦǚǹǠǞǔǝǑǓǗǥǠǩǗǟǑǹǗǞǗ ǜǠǤǜǚǓǟǑǤǥǞǠǢǣǜǑǡǢǠǞǗǟǑǚǣǡǢǗǖǖǗǣǟǗǠǩǟǗǹǑǒǥǩǚǨǗǥǖǗǣǟǠǹ ǣǥǙǟǠǹǘǝǗǙǖǚǡǢǗǩǟǚǜǑǠǖmm
FIGURE 2. A computerized tomograph of the head revealed a tumour in front of the right eyeball in the right lachrymal gland, 26 mm in di-ameter.
SLIKA 4.ƲǢǠǖǠǢǤǥǞǠǢǣǜǚǧǼǗǝǚǹǑǥǗǡǚǤǗǝǘǝǗǙǖǑǟǚǧǑǨǚǟǥǣǑǚ ǚǙǓǠǖǟǚǧǜǑǟǑǝǑǥǠǒǝǚǜǥǝǚǞǦǠǗǡǚǤǗǝǟǚǧǝǗǙǚǹǑ HEǥǓǗǝǚǩǑǻǗ v
FIGURE 4. Penetration of tumour cells into the epithelium of acinus glands and exit channels in the form of lymphoepithelial lesions (HE, magniication ×40).
SLIKA 3.ƵǥǞǠǢǣǜǚǚǟǦǚǝǤǢǑǤǣǥǩǚǟǚǝǚǞǑǝǚǝǚǞǦǠǨǚǤǚǡǠǞǗ ǪǑǟǚǣǑǞǠǟǠǨǚǤǠǚǖǟǚǞBǼǗǝǚǹǑǞǑǼǗǝǚǹǗǣǝǚǩǟǗǨǗǟǤǢǠǨǚǤǚǞǑ ǚǡǝǑǙǞǑǼǗǝǚǹǑǞǑ HEǥǓǗǝǚǩǑǻǗv
FIGURE 3. Tumour iniltration was caused by small lymphocytes mixed with monocytoid B-cells, similar to centrocytes and plasma cells (HE, magniication ×20).
Ê¿¨ÓÎÔÑÒÊΧβ¿ÑÖ¨µ²¸ÑԶδÒѵԨÃÒÊÒÑ É¿Î§¨ÒÒ®¨µÑ¨ÀÉ¿ÃÃÀÒδҵѾ¶´¨®ÎÃÒÎÀÒÎ ÉÎÀÊÎµÑ Ê¶§Î¿Ñ¶ÃÀÒεÀ¶ÓÒεÁ¸Óèɿ´Ò¨»Ñ
od 26mm ³¸¨»Ñ¦¶§Î¿ÀÒ¨µ¼¨¿¨Î¿Ê¿Î¾¶¸
¾¶ÀÒÎÅÓ¶¸ÊÑʨÀÔ¨ª¸Ñ¾Î¿ÑÊ卑À»¨ªÊÀÊÎÔѨ¾¨ ÎÉÀ¨µÑ»ÎÀÊÒÀ¿Á¨¾¨¸¨À¶Òο§Ñ¸Ò¨Â¨¿¶¿¼»¨§ É¿¨ÀʶÉΧʨÉÑÀ¶É¿Î¸ÑʿѸÒο¾¨ÊÎÊΧ¨µ¶¿Ñ ±Òѵ§Ñ»À¨§Ñ¸ÒÑ»Àʨ¿ÉÑ®¨µÑʶ§Î¿Ñ
¨ÀÊθμ»¨Ê¶§Î¿»Îµ¨µÃ¨Ö¶ÓÒΨÒÖ¨¸Ê¿¨ÀÑÎ Ô¤¨ÃÎÁ¸ÓÃÀÑÀÊεÑÎÀÎÃ§Ñ ¨ª¸¨§ÖΨÃÒ¨ª ¤¸¨µÑ»Î§ÉÑ»ÊÒβª¨É¿ª¿Î§Ñʨ´ÒβµÃ¿ÑÎÀ»¶Ã Ò®¨ÊÎɸÑÓ§À¸¨´Ò¨ª®Òʿή¨Ê¨§Ñ»ÑΨ»¿¶É Ò¨ª¸¨§ÖΨÃÒ¨ª¤¸¨µÑξ¨¸ÒÀÔʸ®¨ÊÎɸÑÓ§ §ÎÒή¨ÊΨÃÒB¤¸¨µ»ÎµÀ¶´ÀÊοÑÀÉο±Ò
¶Ô¨Ã¶ÒÎö¸Ñ¨Öλ¶ÀÒοÑÀÉο±Ò¨ª¨§¶Òξ¸Ñ ÀÊÑ˱¶Ê¶§Î¿À»¨§¤¸¨µÑ§Ñ¶Î´ÑÔѸ¨À¶À¨¿Ê »¨ÎÓ¨ÒÎÖ¨¸Ò¨¸¶»Î®¨Ê¨¨É¸Ñӧή¨Ê¨ÑһΠ¸¨»Î§ÀÊѵ¶Î´ÒÉ¿ÎÃοʶ§Î¿À»¨ª¤¸¨µÑ¶É¨ ʸÁ¸ÓÃÑÒ¨ªÑ®¨Ò¶ÀѨ¨ÓÔÎÃÒ¨ª»ÑÒѸѶξ¸¨»¶ ¸¨§ÖÎɨʸҨª¸Ó¨µÑ ³¸¨»¨§¶ÒΪ¨ÀÊÎ
hemijska analiza sa monoklonskim antitelima koja
»Î¿¨ÀÊÀÊ¿ÉÊÑԨèҾ¨ÎʨһΧɸ»ÀÉÎÊԿè¸Ñ
je dijagnozuMALT¸¨§ÖΧÑÀ¶ÓÒÁ¸Ó鸨µÊ¶
§Î¿ÑÀ¶¾¨¸ÉÎӨʨÔÒÓÑLCA,CD20,CD79-αÉÎÔ¿
šinske i citoplazmatskeIgMiHLADRÑÒʨ²Ò
º¸¨»¨ÃΤ¸¨µÑʶ§Î¿Ñµ»ÀÉ¿¨§¨¿ÑÎCD43ÑÒ
ʨ²Ò½Ñ»Î¸¨§ÖΧÀ»ÑÁÑ¿¨¼ÊÑÒ¨À¶¶ÊÔ¿±ÒÑÔÑÒ ÃÀÒÀ¶ÓÒÁ¸ÓþθÀÒ¨»µÀªÎÃÒλ¿¨Ê¿¨µ¶§¨
§Ñ»¸ÑÀ¨Ö¨»Ñ®¨µÉ¿§ÑÒÈ¿¾Î¿ Ann ArborÀÔ¿
stan uI AE»¸¨Ò¨´»¨ÀÊÑ赶§Ð´ ¾Î¸ÀÒ¨»Ñ
µÒÑÀÊÑÔ¹ÒÎÉ¿¨§ÒΧ¸Î»Ñ¸Ò¿ÑèÎÊ¿ÑɨµÀÑ
¶»¶ÉÒΧÃÎÓΧÎÃGyÒѸÁ¨¼Êʶ§Î¿Ñ¶ÓÑÃ
»ÔÑÊÒ¶ÓѼʨʶÎÀÊѸ¨ªÀÊ¿¶»Ê¶¿Ñο¾¨ÊÆòÎÔο ÒÑÊ¿Ñɨµ¶µ¾¨ÎÔ¿¸ÎÉÎÔιÑҶԨöÉÎÊɶҿ §¨À¨µ»ÎµÑÀÎÿÁÑÔѧÀ®¨ÍθÀÒ¨»¿ÃÎÔÒÎ ÃθÑÓ¨ÒÑ»ÎÒʿθ¾¶Ã¶¤¨ÃÑÀ»ÎÃ§Ñ ²¾¿ÎµÑ¾Î ¸ÀÒ¨»ÑÊλΧԿ§ÒѧÎÁµÑԨʨèÀ§¨ÒÎÔÑÒ¨ ξ¸¨»¾Î¸Àʨ
ЭЬяќдяЬфѳ
Ç¿§Ñ ÉÎÃÑ®¨§Ñ ÒѵÒÎÔ¨µ¨ª ÀʶèµÑ Òѵ´¼¤¨ ʨÉҪ仨ÒÀ»Î²¸¨§ÖΧÑÀѸλѸ¨ÓÑ®¨µÎ§¶ÑÃ
neksima oka jeste limfomMALT#%À¸ÃÖ註¶¸
Ò¨¸¨§ÖΧ§ÑÒʸ¤¸¨µÀ»¨¸¨§ÖΧèֶÓÒ¨»¿¶É
ÒΤ¸¨µÀ»¨B¸¨§ÖΧ¸¨§ÖÎɸÑӧή¨ÊÒ¨¨¨Ó¶ÓÊ
no retkoT¤¸¨µÀ»¨¸¨§ÖΧ¨
MALT ¸¨§ÖΧ §Î¿Öθ컨 Îø¨»¶µ¶ ¤¸¨µ
À¸¨´Ò®Òʿή¨Ê¨§Ñ§ÎÒή¨ÊΨÃÒB¤¸¨µÉ¸Ñ
ӧή¨Ê¨¨¸¨§ÖÎɨʸҸӨµ#%ÇΧҶÊÑ §¼ÎÔ¨ÊѤ¸¨µÀ»ÑÀÊ¿¶»Ê¶¿Ñ¶Î´Òѵ§¨»¿ÎÀ»ÎÉ
À»Î§ÑÒѸ¨ÓΧʶ§Î¿Ñ»ÎÃÒѼ²¾Î¸ÀÒ¨»ÑMALT
¸¨§ÖΧ¿ÑÒ¨ª»¸¨Ò¨´»¨ªÀÊÑ赶§ÑÉοèÒÃÎ ¸ÒÊÒβ»¸¨Ò¨´»Î²ÊλÑÎø¨»¶µ¨Ã¶²ÎÓÑÿÁÑÔÑ ¾Î¸ÀʨÒѨÀªÎè¼ÒΧ§Àʶ³¨ÀʧÀ»ÑèÀ§¨ ÒÑ®¨µÑ¾Î¸ÀʨÊλΧöÁ²Ô¿§ÒÀ»Î²É¿¨ÎÃÑÃ
¼ÑÔÑÀ¿Ê»Î¦ÑÎÀξ¨ÒÑMALT¸¨§ÖΧѶÓÉ¿¨
§Ò¶¸Î»Ñ¸ÒÊ¿Ñɨµ´¨Ò¨¨ªÉÎÊÒ®¨µÑ¸ÒΨӸ ´¨Ô¨§#%
Ç¿¨§Ñ¿ÒÎ ¨ÀªÎè¼ÊMALT ¸¨§Ö뤄 §Î²¶ ¾¨
ƴƳƲƴƭƫƢƳƸƫƤƪƢƹƨƮƱƭƶƲưƱƮƨƭƢƳƴƵƤƱ
ÓÒÁ¸ÓûεÀ¶ÉΪ¨ÀÊθμ»Îµ²¿Ñ±¨À¸¨´ÒÉÑ ¿ÎʨÃÒ¨§Á¸ÓÃѧѧβ¶À»¶ÒÃÑ¿ÒÎÀʤ¨¸¨§ÖÎ ¨ÃÒÎÊ»¨ÔÎÉÎÀ¸ª¿ÎÒ¨´ÒβѶÊΨ§¶ÒÀ»Î²ÓÑÉѹ ÑÇ¿§ÑÉÎÃÑ®¨§Ñ¨Ó¸¨Ê¿Ñʶ¿»ÎþθÀÒ¨»Ñ ÀѳµÎ²¿ÒÎÔ¨§ SjögrenÀ¨ÒÿΧΧÉÎÀÊε¨Ô¤¨¿¨
Ó¨»ÓÑ¿ÑÓÔ¨µÑ ¸¨§ÖΧÑɹ¶ÔÑ´Ò¨ª¨À¶ÓÒ¨ªÁ¸ ÓÃÑ#%½ÎÃÒѼ²¾Î¸ÀÒ¨»ÑÒ¨µ¾¨¸Î»¸¨Ò¨´»¨ª
simptoma, niti prisutnihANA, odnosnoSS-BÑÒʨ
ʸѶÀ¿¶§¶¼Ê»ÑÓ¨ÔѸÎÒÑÉ¿¨§Ñ¿Ò¨³µÎ²¿ ÒÎÔÀ¨ÒÿΧ
Za razliku od primarnihMALT¸¨§ÖΧÑο¾¨
ÊѲ¿À¨ÔÒ¨µ¨Î¾¸¨®¨ÒªÎ´»¨ÒÀ»¨ª¸¨§ÖΧÑÎÔ ¸Î»Ñ¸¨ÓÑ®¨µÀ¶É¿Ñ¤Ò¨À¨ÀʧÀ»¨§Ê²Î¾Ñ§Ñ¨§Ñ µ¶Ñ²¿À¨ÔÒ¨µ¨»¸¨Ò¨´»¨ÊλÊÑ»ÎÃѵ¶ ¨ªÎÔθ ´ ÒÎɪÎÃÒζ»¹¶´¨Ê¨¨ª§¨ÎÊ¿Ñɨµ¶#%·¿¶ ÉÑѶÊοѻεÑÀ¾ÑÔ¨¸Ñɿξ¸§Î§¸´ ÑÉ¿¨§Ñ¿ Ò¨ªÎ¿¾¨ÊÒ¨ª¸¨§ÖΧÑÀ¶ÓÑ»¹¶´¨¸¨Ãѵ¶ÎÉ¼Ê Òβ¸Ãѵ¶¤¨ÊλÎÔ¨ª¾Î¸ÀʨɿΧҹ¨Ô¨ÓѪÊÔÑ §¶¸Ê¨Ã¨À®¨É¸¨ÒÑ¿ÒÎÊ¿ÑɨµÀ»Î¸´ #%Ë ±¶Ê¨§¨§Ñ¨Ñ¶Êοѻε¨À§Ñʿѵ¶Ãѵ¿ÑèÎÊ¿Ñɨ µÑÀѪ§¨ÎÊ¿ÑɨµÎ§¨¸¨¾Ó ÒÓÑξ¨¸ÑÓÒÑÊ¿Ñ É¨µÀ»Ñ§Î²¶¤ÒÎÀÊ»ÑÃÑÀ¶¶É¨ÊÑ ¶É¿¨§Ñ¿Ò¨¸¨§ÖÎ §¨Î¿¾¨Ê#%
ÅÑ®¨ÎÒѸÑÒÉ¿¨Àʶɶ¸´ ¶¾Î¸ÀÒ¨»ÑÀÉ¿¨
marnimMALT¸¨§ÖΧΧÑÃÒ»ÀÑλÑÊ¿¾ÑÓÑÀÒÎ
ÔÑʨÒÑÉÎÃÑ®¨§Ñ¨Ó¸¨Ê¿Ñʶ¿¦Ñ»Î¶ÃÎÀÑÃÑÒѵ ¾¿ÎµÒ¨µÎµÀʶ赨ÎüÀʾθÀÒ¨»ÑÀѸ¨§ÖΧ¨§Ñ
À¶ÓÒ¨ªÁ¸ÓÃÑ«Ö¿¨ Jeffrey¨ÀÑ¿ÑÃÒ¨®¨#%É¿¨
»ÑÓ¶µ¶´Ê¨¿¨ÀÑMALT¸¨§ÖΧΧ³ÔѴʨ¿¨¾Î¸
ÀÒ¨»ÑÀ¶¸´ÒÑÉ¿¨§ÒΧÀ¶ÉÊÎÊѸҪ¨¿¶¿¼»¿ À»®¨µ¨ÉÎÀÊÎÉ¿Ñ®¨ÎÒβ¸Î»Ñ¸ÒβӿѴ Ñ
ьѳќъдгѳќ
£¨Ó¾Î¿¶¸´ ѾθÀÒ¨»ÑÀÉ¿¨§Ñ¿Ò¨§MALT
¸¨§ÖΧΧÀ¶ÓÒ¨ªÁ¸ÓÃÑÉ¿¨Ã¿¶Á¶µ§ÎÀ²¿¶É¨ ѶÊοѻεÑÀ§ÑÊ¿ÑÃѵ®¨¹ÑÒÑ¿ÑèÎÊ¿ÑɨµÑÉÎ À¸ª¨¿¶¿¼»¿À»®¨µÃÎÔιÒÑÓѶÔα ¾Î¸ ÀÒ¨»Ñ¶ÉÎÊɶҶ¿§¨À¨µ¶¾Î¸Àʨ#%
LITERATURA
1. Cavalli F. Extranodal lymphomas. In: Magrath IV, editor. The Non-Hodgkin’s lymphomas. London: Arnold; 1997. p.1007.
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the Inter-national Lymphoma Study Group. Blood 1994; 84:1361-92. 3. Isaacson PG, Muller-Hermelink HK, Piris MA, et al. Extranodal
marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vard-iman JW, editors. Pathology & Genetics: tumours of haematopoi-etic and lymphoid tissues. World Health Organization Classifica-tion of Tumours. Lyon, France: IARC Press; 2001. p.157-60. 4. Ochoa ER, Harris NL, Pilch BZ. Marginal zone B-cell lymphoma
of the salivary gland arising in chronic sclerosing sialoadenitis (Kuttner Tumor). Am J Surg Pathol 2001; 25(12):1546-50. 5. Zufferey P, Meyer OC, Grossin M, et al. Primary Sjögren’s
Syn-drome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Reumatol 1995; 24:342-5. 6. Raderer M, Vorbeck F, Formanek M, et al. Importance of extensive
staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 2000; 83(4):454-7. 7. Isaacson PG. Mucosa-associated lymphoid tissue lymphoma.
Semin in Hematol 1999; 36:139-47.
8. Cho EY, Han JJ, Ree HJ, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 2003; 73:87-96. 9. Auw-Haedrich C, Coupland SE, Kapp A, Schmitt-Graff A, Buchen
R, Witschel H. Long-term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma. Br J Ophthalmol 2001; 85(1):63-9. 10. Agulnik M, Tsang R, Baker MA, Kazdan MS, Fernandes B.
Malig-nant lymphoma of mucosa-associated lymphoid tissue of the lach-rymal gland: case report and review of literature. Am J Clin Oncol 2001; 24(1):67-70.
11. Kiratli H, Soylemezoglu F, Bilgic S, Ruacan S. Mucosa-associated lymphoid tissue lymphoma of the lachrymal gland. Ophthal Plast Reconstr Surg 1999; 15(4):272-6.
12. Cahill M, Barnes C, Moriarty P, et al. Ocular adnexal lymphoma – comparison of MALT lymphoma with other histological types. Br J Ophthalmol 1999; 83:742-7.
13. Galieni P, Polito E, Leccisotti A, et al. Localized orbital lymphoma. Haematologica 1997; 82(4):436-9.
14. Coupland SE, Krause L, Delecluse HJ, Anagnostopoulos I, Foss HD, Hummel M, Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 1998; 105(8):1430-41. 15. Čolović M, Janković G, Čemerikić-Martinović V, Latković Z,
Don-frid M. Primary intraocular marginal zone B-cell (MALT) lym-phoma. Eur J Haematol 1997; 58:1-2.
16. Lee SW, Suh GO, Kim GE, et al. Role of radiotherapy for primary orbital lymphoma. Am J Clin Oncol 2002; 25:261-5.
17. Schick U, Lermen O, Unsold R, Hassler W. Treatment of primary orbital lymphomas. Eur J Haematol 2004; 72(3):186-92.
18. Jeffrey PB, Cartwright D, Atwater SK, et al. Lachrymal gland lym-phoma: a cytomorphologic and immunophenotypic study. Diagn Cytopathol 1995; 12:215-22.
ƴƳƲƴƭƫƢƳƸƫƤƪƢƹƨƮƱƭƶƲưƱƮƨƭƢƳƴƵƤƱ
ABSTRACT
Mucosa-associated lymphoid tissue (MALT) lymphoma has drawn attention in the last twenty years due to its pathological and clinical characteristics. It is a question of B-cell neoplasm with extranodal origin, and with invariable prolonged locali-sation, indicating indolent malignancy. It is believed that this type of lymphoproliferative neoplasm is triggered by chron-ic antigenchron-ic stimulation. This is supported by the observation that this type of extranodal lymphoma is frequently found in regions affected by chronic inflammation, such as mucosa of the stomach, the respiratory tract, as well as of the salivary and the thyroid glands. It is not common in the breasts, liver, kidneys, and gallbladder. Primary orbital lymphomas account for 5-14% of all extranodal lymphomas. The most commonly involved orbital tissue structures are: conjunctiva, the eyelids, and retrobulbar tissue, while the development of the disease in the lachrymal gland is extremely rare. No wonder that the
lit-erature on the presentation, treatment modalities, and recom-mendations for the monitoring of MALT lymphoma of the lach-rymal gland is so scarce. Given the aforementioned facts, the case report of a patient with primary localisation of MALT lym-phoma of the lachrymal gland was considered intriguing; ini-tially, the patient was successfully treated by surgical interven-tion followed by radiainterven-tion therapy (TD 30 Gy).
Key words: MALT lymphoma; lachrymal gland; radiation therapy
Ružica NEDELJKOV-JANČIĆ Institut za hematologiju Klinički centar Srbije
Dr Koste Todorovića 2, 11000 Beograd Tel: 011 361 7777, lokal 3723
E-mail: ruzicajn@yahoo.com
MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA
OF THE LACHRYMAL GLAND – A CASE REPORT
Ružica NEDELJKOV-JANČIĆ, Biljana MIHALJEVIĆ, Milena BAKRAČ, Milan PETROVIĆ Institute of Haematology, Clinical Centre of Serbia, Belgrade